If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
21.50    0.00 (0.00%)
Bid:
21.00
Ask:
22.00
Spread: 1.00 (4.762%)
Market Cap: £23.22m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

FY26 Trading Update

19 Feb 2026 07:00

RNS Number : 5804T
Checkit PLC
19 February 2026
 

Checkit plc

("Checkit" or the "Company")

 

FY26 Trading Update

Cash generation and EBITDA profit in the second half

 

Checkit plc (AIM: CKT), the automated monitoring and operational intelligence platform for frontline-led organisations, provides an update on trading for the year ended 31 January 2026 based on unaudited management accounts ("FY26").

Highlights

· Full year Adjusted EBITDA2 at break-even, ahead of market expectations, following delivery of £4.0m of annualised cost savings

· Positive Adjusted EBITDA2 of £0.5m in H2 FY26

· Net cash of £3.0m at year end (£2.7m at 31 July 2025), ahead of market expectations, reflecting a cash-generative H2

· Annual Recurring Revenue1 ("ARR") of £14.3m, a fall of 1%, but up 2% at constant currency, with underlying ARR growth of 5% excluding a single large US customer reduction, as announced in the Company's interim results

· Recurring revenue increased to 96% of total revenue

Financial Summary

£m

31 January 2026

FY26

31 January 2025

FY25

Percentage change

Group revenue

13.7

14.1

(2%)

Recurring revenue - percentage of revenue

96%

94%

2%

ARR1

14.3

14.4

(1%)

Constant currency ARR1

14.3

14.0

2%

Adjusted EBITDA2

0.0

(2.3)

100%

Net cash

3.0

5.1

(41%)

 

Operational and Commercial Update

In FY26 management prioritised profitability, cash generation and quality of revenue. The delivery of break-even Adjusted EBITDA for the full year, combined with a profitable and cash-generative second half, marks a significant inflection point for the Group.

ARR performance reflects active portfolio management and includes the impact of a £0.4m ARR contraction from one large US customer, as announced at the Interim Results. Excluding this item, underlying ARR grew by 5% at constant currency, supported by renewal activity. Contract durations also increased across approximately a quarter of the revenue base, enhancing forward revenue visibility and overall revenue quality.

Total revenue declined modestly due to lower non-recurring revenue, while recurring revenue increased, further improving the quality and visibility of earnings.

Outlook

The Group enters FY27 with a materially lower cost base, improved operational discipline and a high quality pipeline compared with the prior year. In the year ahead, the Group will continue to refine its resource allocation, with increased emphasis on its core platform, which the Board believes offers the strongest long-term value opportunity for shareholders.

Investment focus is now shifting towards growth initiatives, including the rollout of a new user interface and continued development of the platform's operational intelligence capabilities, while maintaining tight financial discipline.

Kit Kyte, Chief Executive Officer, commented:

"FY26 was a pivotal year for Checkit. We completed a structural reset of the business, delivered Adjusted EBITDA break-even ahead of market expectations and generated cash in the second half. Importantly, we have strengthened the quality of our recurring revenue base through long-term renewals and disciplined commercial decision-making. With a lower cost base and a strong pipeline, we enter FY27 positioned to pursue growth."

NOTES

 

1 Annual Recurring Revenue is defined as the annualised value of contracted recurring revenue from subscription services as at the period end, including committed but yet to commence annual recurring revenue. Constant currency comparatives are calculated using exchange rates prevailing at 31 January 2026.

2 Adjusted EBITDA is the profit on operating activities before depreciation and amortisation, share based payment charges and non-recurring or exceptional items.

 

Enquiries:

Checkit plc

 

+44 (0) 1223 643313

www.Checkit.net

 

Kit Kyte (Chief Executive Officer)

 

Kris Shaw (Chief Financial Officer)

 

Singer Capital Markets (Nominated Adviser & Broker)

 

+44 (0) 20 7496 3000

Shaun Dobson / Peter Steel / James Fischer

Yellowstone Advisory (Investor Relations)

 

+44 (0) 203 951 8907

Alex Schlich

alex@yellowstoneadvisory.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTTPMTTMTBBTPF
Date   Source Headline
21st Apr 20267:00 amRNSFinal Results
20th Apr 202610:34 amRNSForm 8.5 (EPT/RI) - Replacement
20th Apr 20269:53 amRNSForm 8.5 (EPT/RI)
17th Apr 202610:37 amEQSForm 8.3 - Checkit PLC
17th Apr 20269:37 amRNSForm 8.5 (EPT/RI)
16th Apr 202610:48 amRNSForm 8.3 - Checkit PLC
16th Apr 20269:57 amRNSForm 8.5 (EPT/RI)
15th Apr 20269:31 amRNSForm 8.5 (EPT/RI)
14th Apr 20262:00 pmEQSForm 8.3 - Checkit plc
14th Apr 202610:03 amRNSForm 8.5 (EPT/RI)
13th Apr 20262:29 pmEQSForm 8.3 - Checkit plc
13th Apr 202611:46 amRNSForm 8.5 (EPT/RI)
10th Apr 202612:47 pmEQSForm 8.3 - Checkit PLC
10th Apr 202611:58 amRNSForm 8.5 (EPT/RI)
9th Apr 202611:34 amRNSForm 8.5 (EPT/RI)
9th Apr 20268:04 amEQSForm 8.3 - Checkit PLC
8th Apr 202612:51 pmRNSForm 8.3 - Checkit PLC
8th Apr 202612:48 pmRNSHolding(s) in Company
8th Apr 20269:54 amRNSForm 8.5 (EPT/RI)
7th Apr 202611:44 amRNSForm 8.3 - Checkit plc
7th Apr 202610:30 amRNSForm 8.5 (EPT/RI)
1st Apr 202610:37 amRNSForm 8.5 (EPT/RI)
1st Apr 20269:38 amRNSForm 8.3 - Checkit PLC
1st Apr 20267:47 amRNSForm 8 (OPD) - Checkit plc
31st Mar 20262:50 pmEQSForm 8.3 - Checkit PLC
31st Mar 202611:29 amRNSForm 8.3 - Checkit plc
31st Mar 202611:12 amRNSHolding(s) in Company
31st Mar 202610:51 amRNSForm 8.5 (EPT/RI)
30th Mar 20261:58 pmRNSForm 8.3 - Checkit plc
30th Mar 202610:14 amRNSForm 8.5 (EPT/RI)
27th Mar 20263:39 pmRNSForm 8.3 Check it
27th Mar 20262:43 pmRNSForm 8.3 - Checkit PLC
27th Mar 202611:44 amRNSForm 8.3 - Checkit plc
27th Mar 202611:36 amEQSForm 8.3 - Checkit PLC
27th Mar 202610:40 amRNSForm 8.5 (EPT/RI)
27th Mar 202610:32 amRNSCheckit Plc - Form 8.3
26th Mar 202610:26 amRNSForm 8.3 - Checkit PLC
26th Mar 20267:45 amRNSDisclosure Table
26th Mar 20267:00 amRNSCommencement of Formal Sale Process
19th Feb 20267:00 amRNSFY26 Trading Update
21st Jan 202611:34 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
30th Oct 20251:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.